You are here

  • Home
  • Archive
  • Volume 9, Issue 10
  • Leveraging immune memory against measles virus as an antitumor strategy in a preclinical model of aggressive squamous cell carcinoma

Article info

Article menu
Oncolytic and local immunotherapy
Leveraging immune memory against measles virus as an antitumor strategy in a preclinical model of aggressive squamous cell carcinoma

Authors

  • Victoria M Leb-Reichl EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria PubMed articlesGoogle scholar articles
  • Melanie Kienzl EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria PubMed articlesGoogle scholar articles
  • Anna Kaufmann EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria PubMed articlesGoogle scholar articles
  • Angelika Stoecklinger Department of Biosciences, University of Salzburg, Salzburg, Austria PubMed articlesGoogle scholar articles
  • Birgit Tockner EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria PubMed articlesGoogle scholar articles
  • Sophie Kitzmueller EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria PubMed articlesGoogle scholar articles
  • Nadja Zaborsky Salzburg Cancer Research Institute—Laboratory for Immunological and Molecular Cancer Research, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria PubMed articlesGoogle scholar articles
  • Markus Steiner Salzburg Cancer Research Institute—Laboratory for Immunological and Molecular Cancer Research, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria PubMed articlesGoogle scholar articles
  • Gabriele Brachtl Experimental and Clinical Cell Therapy Institute, Spinal Cord Injury & Tissue Regeneration Center, Paracelsus Medical University Salzburg, Salzburg, Austria PubMed articlesGoogle scholar articles
  • Lisa Trattner EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria PubMed articlesGoogle scholar articles
  • Patrick Kreideweiss Lipocalyx GmbH, Halle, Germany PubMed articlesGoogle scholar articles
  • Christian Reinsch Lipocalyx GmbH, Halle, Germany PubMed articlesGoogle scholar articles
  • Steffen Panzner Lipocalyx GmbH, Halle, Germany PubMed articlesGoogle scholar articles
  • Richard Greil Salzburg Cancer Research Institute—Laboratory for Immunological and Molecular Cancer Research, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria PubMed articlesGoogle scholar articles
  • Dirk Strunk Experimental and Clinical Cell Therapy Institute, Spinal Cord Injury & Tissue Regeneration Center, Paracelsus Medical University Salzburg, Salzburg, Austria PubMed articlesGoogle scholar articles
  • Johann W Bauer EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria PubMed articlesGoogle scholar articles
  • Iris K Gratz EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, AustriaDepartment of Biosciences, University of Salzburg, Salzburg, Austria PubMed articlesGoogle scholar articles
  • Christina Guttmann-Gruber EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria PubMed articlesGoogle scholar articles
  • Josefina Piñón Hofbauer EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria PubMed articlesGoogle scholar articles

Citation

Leb-Reichl VM, Kienzl M, Kaufmann A, et al
Leveraging immune memory against measles virus as an antitumor strategy in a preclinical model of aggressive squamous cell carcinoma
Journal for ImmunoTherapy of Cancer 2021;9:e002170. doi: 10.1136/jitc-2020-002170
Online issue publication 
June 27, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.